Evaxion Biotech A/S (EVAX:NASDAQ) closed at $3.08 on October 27, 2026, up 0.08% on the day. The stock trades 55.5% below its 52-week high of $6.92 and 13.3% above its 52-week low of $2.72. Over the past year, it lost 49.8%. Evaxion Biotech A/S is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, EVAX closed higher on 116 days (46%). Its best day was October 20, 2026 (+21.62%) and its worst was December 19, 2025 (-18.26%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 3 times.
Evaxion Biotech AS is an artificial intelligence immunology platform company. It uses proprietary AI technology, engineering expertise, and drug development know-how to simulate the human immune system and generate predictive models to identify and develop efficacious immunotherapies for patients in the global market. Its two lead product candidates are EVX-01 and EVX-02, for the treatment of various cancers.
Find more stocks like EVAX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.